Skye Bioscience Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.9821 +0.01 (+0.95%) USD | NASDAQ | Jan 21, 16:00

0.9821 0.00 (0.00%) After-Hours: 20:00

View Preferred Securities out of Shareholders Equity (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	--
Theravance Biopharma, Inc.	--
Viking Therapeutics, Inc.	--
Kyntra Bio, Inc.	--
Myomo, Inc.	--